CH507983A - Verfahren zur Herstellung von Cephalosporansäurederivaten - Google Patents

Verfahren zur Herstellung von Cephalosporansäurederivaten

Info

Publication number
CH507983A
CH507983A CH1507467A CH1507467A CH507983A CH 507983 A CH507983 A CH 507983A CH 1507467 A CH1507467 A CH 1507467A CH 1507467 A CH1507467 A CH 1507467A CH 507983 A CH507983 A CH 507983A
Authority
CH
Switzerland
Prior art keywords
preparation
acid derivatives
cephalosporanic acid
cephalosporanic
derivatives
Prior art date
Application number
CH1507467A
Other languages
English (en)
Inventor
Hans Dr Bickel
Rolf Dr Bosshardt
Bruno Dr Fechtig
Enrico Dr Menard
Johannes Dr Mueller
Heinrich Dr Peter
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Priority to CH1507467A priority Critical patent/CH507983A/de
Priority to US739628A priority patent/US3639396A/en
Priority to DE19681770712 priority patent/DE1770712A1/de
Priority to GB30543/68A priority patent/GB1237742A/en
Priority to NL6809474A priority patent/NL6809474A/xx
Priority to FR1588507D priority patent/FR1588507A/fr
Publication of CH507983A publication Critical patent/CH507983A/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/187-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
CH1507467A 1967-07-05 1967-10-27 Verfahren zur Herstellung von Cephalosporansäurederivaten CH507983A (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CH1507467A CH507983A (de) 1967-07-05 1967-10-27 Verfahren zur Herstellung von Cephalosporansäurederivaten
US739628A US3639396A (en) 1967-07-05 1968-06-25 Derivatives of 7-aminocephalosporanic acid
DE19681770712 DE1770712A1 (de) 1967-07-05 1968-06-26 Verfahren zur Herstellung von Cephalosporansaeurederivaten
GB30543/68A GB1237742A (en) 1967-07-05 1968-06-26 Process for the manufacture of cephalosporanic acid derivatives
NL6809474A NL6809474A (de) 1967-07-05 1968-07-04
FR1588507D FR1588507A (de) 1967-07-05 1968-07-04

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH949767 1967-07-05
CH1507467A CH507983A (de) 1967-07-05 1967-10-27 Verfahren zur Herstellung von Cephalosporansäurederivaten

Publications (1)

Publication Number Publication Date
CH507983A true CH507983A (de) 1971-05-31

Family

ID=25704899

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1507467A CH507983A (de) 1967-07-05 1967-10-27 Verfahren zur Herstellung von Cephalosporansäurederivaten

Country Status (6)

Country Link
US (1) US3639396A (de)
CH (1) CH507983A (de)
DE (1) DE1770712A1 (de)
FR (1) FR1588507A (de)
GB (1) GB1237742A (de)
NL (1) NL6809474A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5946292A (ja) * 1982-09-09 1984-03-15 Otsuka Chem Co Ltd 2−置換セフエム誘導体の製造法

Also Published As

Publication number Publication date
FR1588507A (de) 1970-04-17
GB1237742A (en) 1971-06-30
US3639396A (en) 1972-02-01
DE1770712A1 (de) 1972-01-13
NL6809474A (de) 1969-01-07

Similar Documents

Publication Publication Date Title
AT303955B (de) Verfahren zur Herstellung von Cephalosporinderivaten
CH511233A (de) Verfahren zur Herstellung von Isochinuklidin-Derivaten
CH515275A (de) Verfahren zur Herstellung von Derivaten von Cephalosporin C
CH507248A (de) Verfahren zur Herstellung von D-6-Methylergolin(I)ylessigsäure
CH541580A (de) Verfahren zur Herstellung von Bis-thioureidobenzol-derivaten
CH529145A (de) Verfahren zur Herstellung von 1-Aminoalkylbenzodiazepinderivaten
CH516587A (de) Verfahren zur Herstellung von Benzothiazepinderivaten
CH526538A (de) Verfahren zur Herstellung von Aminophenylessigsäure-Derivaten
CH518301A (de) Verfahren zur Herstellung von Dibenzothiazepin-Derivaten
CH544773A (de) Verfahren zur Herstellung von Cephalosporansäure-Derivaten
CH504473A (de) Verfahren zur Herstellung von Cephalosporansäurederivaten
AT273953B (de) Verfahren zur Herstellung von v-Triazolyl-cumarinderivaten
AT299447B (de) Verfahren zur Herstellung von 7-Aminocephalosporansäure
CH500935A (de) Verfahren zur Herstellung von Phenylsalicylsäure-Verbindungen
CH507233A (de) Verfahren zur Herstellung von Kalamycinderivaten
CH519518A (de) Verfahren zur Herstellung von 7-Aminocephalosporansäure
AT309676B (de) Verfahren zur Herstellung von 7-Aminocephalosporansäure-Derivaten
CH508589A (de) Verfahren zur Herstellung von B-Aminocarbonsäurederivaten
CH507983A (de) Verfahren zur Herstellung von Cephalosporansäurederivaten
AT286960B (de) Verfahren zur Herstellung der d-trans-Pyrethrinsäure
AT273117B (de) Verfahren zur Herstellung von Tetrazolderivaten
CH478745A (de) Verfahren zur Herstellung von Aryloxyessigsäurederivaten
CH538449A (de) Verfahren zur Herstellung von Aminophenylessigsäure- Derivaten
CH484193A (de) Verfahren zur Herstellung von Derivaten der Cephalosporan-Säure
CH509962A (de) Verfahren zur Herstellung von Phenylsalicylsäure-Verbindungen

Legal Events

Date Code Title Description
PL Patent ceased